The PACS Group, Inc. (NYSE: PACS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a healthcare holding company in the post-acute care and medical care facilities space, PACS uses SEC reports to describe its facility portfolio, credit arrangements, governance, and risk profile.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of PACS Group’s operations, financial condition, and risk factors. These filings also provide context on the company’s role as a holding company, the structure of its independent operating subsidiaries, and the separation between licensed healthcare providers and non-provider entities. AI-generated highlights can point out key sections on post-acute care operations, use of credit facilities, and lease obligations.
Current reports on Form 8-K are particularly important for PACS, given its history of restatements, credit agreement amendments, and NYSE listing updates. Recent 8-K filings have addressed topics such as forbearance and amendments under the company’s amended and restated credit agreement, events of default and related waivers, NYSE listing extensions tied to delayed SEC filings, and the completion of an independent Audit Committee investigation and related restatements. AI summaries can help users quickly understand the implications of these events.
Users can also access proxy materials such as the Definitive Proxy Statement on Schedule 14A, which outlines matters presented to stockholders at the annual meeting, including director elections, auditor ratification, and advisory votes on executive compensation. In addition, the filings page provides real-time updates from EDGAR and convenient access to other forms, such as notifications of late filings on Form 12b-25. Together, these documents offer a comprehensive view of PACS Group’s regulatory history, governance decisions, and financial reporting, with AI tools available to simplify and explain complex disclosures.
PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received an award of 30,000 shares of common stock in the form of restricted stock units. Each RSU converts into one share upon vesting. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of December 1, 2025, contingent on continued service.
PACS Group, Inc. reported that Chief Human Resources Officer Trent Dean Bingham received a grant of 25,000 shares of Common Stock in the form of restricted stock units. Each RSU converts into one share upon vesting, in substantially equal annual installments on the first, second, and third anniversaries of November 10, 2025, contingent on continued service.
PACS Group, Inc. filed an initial ownership report on Form 3 for Kelly Priegnitz, who serves as Chief Compliance Officer. The filing establishes her status as an officer subject to insider reporting rules but does not list any specific transactions or share amounts.
PACS Group, Inc. executive Bingham Trent Dean, the company’s Chief Human Resources Officer, has filed an initial Form 3 reporting his status as an officer of the company. The filing does not report any insider buy, sell, acquisition, or disposal transactions in PACS Group stock.
PACS Group, Inc. reports strong full-year 2025 results as a leading U.S. post-acute and skilled nursing operator. The company generated $5.3 billion in total revenue, with net income of $191.5 million and Adjusted EBITDA of $505.0 million, reflecting rapid multi-year growth.
PACS operates 321 post-acute care facilities across 17 states, serving over 31,700 patients daily, and focuses on transforming underperforming nursing homes into higher-acuity, short-term transitional care centers. Mature facilities posted an average QM Star rating of 4.4 and 95% occupancy, exceeding industry averages.
The business is highly dependent on Medicare and Medicaid, which supplied 33.7% and 40.5% of routine revenue in 2025, and carries $3.6 billion of total long-term liabilities. Management highlights a disciplined acquisition strategy, technology-enabled support services, and significant future growth opportunities in real estate ownership and ancillary services.
PACS Group, Inc. reported strong growth for 2025, with revenue of $5.29 billion, up 29.3% from the prior year, and net income of $191.5 million. Adjusted EBITDA reached $505.0 million and Adjusted EBITDAR was $883.9 million, reflecting higher scale and profitability.
Fourth-quarter 2025 revenue was $1.36 billion, up 12.4% year over year, with net income of $59.8 million and Adjusted EBITDA of $142.1 million. Cash from operating activities was $404.2 million, and cash and cash equivalents were $197.0 million as of December 31, 2025. For 2026, the company expects revenue of $5.65–$5.75 billion and Adjusted EBITDA of $555–$575 million, supported by a 323‑facility portfolio and continued expansion.
PACS Group, Inc. Chief Accounting Officer reports tax withholding share transaction. Michelle Renee Lewis reported that on 01/15/2026, 3,348 shares of PACS Group, Inc. common stock were withheld at a price of $39.49 per share. The filing explains this was a payment of tax liability through the withholding of shares upon the vesting of previously granted and reported restricted stock units. After this transaction, Lewis beneficially owned 374,870 shares of PACS Group, Inc. common stock, held directly.
PACS Group, Inc. Chief Legal Officer and Secretary John Todd Mitchell reported a Form 4 transaction involving company common stock. On 01/15/2026, 9,541 shares of PACS Group common stock were withheld at a price of $39.49 per share. According to the footnote, this was a payment of tax liability through the withholding of shares upon the vesting of previously granted and reported restricted stock units, rather than an open-market sale. Following this tax withholding, Mitchell directly beneficially owned 868,150 shares of PACS Group common stock.
PACS Group, Inc. President & COO Joshua Jergensen reported a routine tax-withholding transaction in company common stock. On January 15, 2026, 21,998 shares of PACS Group common stock were withheld at a reference price of $39.49 per share, coded as an "F" transaction, which the disclosure explains was to pay tax liabilities arising from the vesting of previously granted restricted stock units.
Following this withholding, Jergensen beneficially owns 2,703,682 shares of PACS Group common stock, held directly. This filing reflects administrative share withholding for taxes rather than an open-market sale.
PACS Group, Inc. reported an insider equity transaction by Mark Hancock, a director, co-founder, interim CFO, executive vice chair, and 10% owner. On January 15, 2026, 12,774 shares of common stock were withheld at $39.49 per share to satisfy tax liabilities arising from the vesting of previously granted and reported restricted stock units. This was recorded as a disposition under code F, which denotes tax withholding rather than an open-market sale. Following this transaction, Hancock beneficially owns 54,804,443 shares of PACS Group common stock in direct ownership.